Standard BioTools Inc. LAB
Standard BioTools Inc. (Nasdaq: LAB) is a life-science tools company. Its next catalyst on record is Merger with Treeline Biosciences: Special stockholder meeting to vote on Merger proposals (November 2026).
Upcoming catalysts
- November 2026Merger with Treeline Biosciences — Special stockholder meeting to vote on Merger proposals
The special meeting of our stockholders to vote on the proposals related to the Merger and the sale of the Mass Cytometry Business is scheduled for November 19, 2026.
Next further out: Merger with Treeline Biosciences — Expected closing of Merger (Q4 2026). 1 catalyst on record beyond the next 30 days; subscribers see each with its filing sentence.
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.